Indian Journal of Private Psychiatry

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  18 (2024)
Volume  17 (2023)
Volume  16 (2022)
Volume  15 (2021)
Volume  14 (2020)
Volume  13 (2019)
Volume  12 (2018)
Volume  11 (2017)
Related articles

VOLUME 17 , ISSUE 1 ( January-June, 2023 ) > List of Articles

Original Article

Neuropsychiatric Manifestations of COVID-19: An Online Survey

Kaustav Chakraborty, Moumita Chatterjee, Rajarshi Neogi, Ranjan Bhattacharyya, Munish Agarwal, Soumya Chatterjee, Gautam Saha

Keywords : Coronavirus disease, Neuropsychiatric, Psychiatric, Symptoms

Citation Information : Chakraborty K, Chatterjee M, Neogi R, Bhattacharyya R, Agarwal M, Chatterjee S, Saha G. Neuropsychiatric Manifestations of COVID-19: An Online Survey. Ind J Priv Psychiatry 2023; 17 (1):26-33.

DOI: 10.5005/jp-journals-10067-0136

License: CC BY-NC 4.0

Published Online: 10-02-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Background: Coronavirus disease-2019 (COVID-19) is known to cause neuropsychiatric sequelae. However, there is dearth of data regarding the same from this subcontinent. Aim and objectives: To determine the prevalence of neuropsychiatric symptoms among patients who recovered from COVID-19 illness. Materials and methods: It was an online survey that was conducted by using Google form with link sent by using WhatsApp to subjects who suffered and recovered from COVID-19 illness. The online survey was done through a 71-item self-designed questionnaire. It took around 10 minutes to complete the questionnaire. In total, 250 responses were received. Results: A typical subject was male (63.2%), healthcare provider (33.6%), Hindu (96.4%) by religion, and from urban background (74%). Nearly about two-fifths (43.2%) and one-fifth (20.8%) of the subjects had comorbid physical and psychiatric disorders, respectively. Majority of the subjects had COVID-19 illness in the past 1 month. Nearly about one-sixth (17.6%) of the subjects lost somebody in their family due to COVID-19. Majority (59.2%) of the subjects experienced persistent fatigue after recovering from COVID-19. Nearly about one-third of the subjects experienced persistent low mood (34.8%), sleep difficulty (38.8%), anxiety symptoms (39.6%), irritability (34.4%), difficulty in concentrating (39.6%), and forgetfulness (30.8%). Nearly about one-sixth of the subjects had panic attacks (18.4%), flashback of illness (16%), obsessive–compulsive symptoms (18.8%), and sexual difficulty (16%) after recovering from COVID-19. Nearly half of the subjects became more preoccupied about bodily symptoms (45.6%), became more anxious on reading COVID-19-related news (45.2%), and hence avoided the same (49.6%). Nearly about one-fifth of the subjects had persistent loss of smell (25.6%), taste (20.4%), and brain fog (26.4%). A miniscule proportion of the subjects had new-onset headache (15.2%), giddiness (12%), and tremor of hands (9.6%). Conclusion: The index survey suggested that neuropsychiatric symptoms are quite prevalent after recovering from COVID-19 illness.

HTML PDF Share
  1. Coronavirus [cited 2022 April 8]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
  2. Chen Q, Liang M, Li Y, et al. Mental health care for medical staff in China during the COVID-19 outbreak. Lancet Psychiatry 2020;7(4):e15–e16. DOI: 10.1016/S2215-0366(20)30078-X.
  3. Yang Y, Li W, Zhang Q, et al. Mental health services for older adults in China during the COVID-19 outbreak. Lancet Psychiatry 2020;7(4):e19. DOI: 10.1016/S2215-0366(20)30079-1.
  4. Grover S, Sahoo S, Mehra A, et al. Psychological impact of COVID-19 lockdown: An online survey from India. Indian J Psychiatry 2020;62(4):354–362. DOI: 10.4103/psychiatry.IndianJPsychiatry_427_20.
  5. Grover S, Rani S, Mehra A, et al. COVID-19 pandemic: A crisis for health-care workers. J Mental Health Hum Behav 2020;25(1):1–4. DOI: 10.4103/jmhhb.jmhhb_96_20.
  6. Chakraborty K, Chatterjee M. Psychological impact of COVID-19 pandemic on general population in West Bengal: A cross-sectional study. Indian J Psychiatry 2020;62(3):266–272. DOI: 10.4103/psychiatry.IndianJPsychiatry_276_20.
  7. Chakraborty K, Chatterjee M, Bhattacharyya R, et al. Psychological impact of ‘lockdown’ on behaviour of children during COVID-19 pandemic: An online survey. J Indian Assoc Child Adolesc Ment Health 2021;17(2):72–86. https://doi.org/10.1177/0973134220210205.
  8. Li Z, Ge J, Yang M, et al. Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control. Brain Behav Immun 2020;88:916–919. DOI: 10.1016/j.bbi.2020.03.007.
  9. Chan JFW, Zhang AJ, Yuan S, et al. Simulation of the clinical and pathological manifestations of Coronavirus disease 2019 (COVID-19) in golden Syrian hamster model: Implications for disease pathogenesis and transmissibility. Clin Infect Dis 2020;71(9):2428–2446. DOI: 10.1093/cid/ciaa325.
  10. Perlman S, Evans G, Afifi ADEL. Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain. J Exp Med 1990;172(4):1127–1132. DOI: 10.1084/jem.172.4.1127.
  11. Banerjee D, Viswanath B. Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses. Asian J Psychiatr 2020;54:102350. DOI: 10.1016/j.ajp.2020.102350.
  12. Sachdev K, Agrawal S, Ish P, et al. Neurological manifestations of COVID-19: A brief review. Indian J Med Res 2020;152(1 and 2):41–47. DOI: 10.4103/ijmr.IJMR_1395_20.
  13. Liu K, Chen Y, Lin R, et al. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect 2020;80(6):e14–e18. DOI: 10.1016/j.jinf.2020.03.005.
  14. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur Arch Otorhinolaryngol 2020;277(8):2251–2261. DOI: 10.1007/s00405-020-05965-1.
  15. Fischer M, Coogan AN, Faltraco F, et al. COVID-19 paranoia in a patient suffering from schizophrenic psychosis – A case report. Psychiatry Res 2020;288:113001. DOI: 10.1016/j.psychres.2020.113001.
  16. Zulkifli NA, Sivapatham S, Guan NC. Brief psychotic disorder in relation to coronavirus, COVID-19 outbreaks: A case report. Malaysian J Psychiatry 2020;29(1):67–72.
  17. Moriguchi T, Harii N, Goto J, et al. A first case of Meningitis encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 2020;94:55–58. DOI: 10.1016/j.ijid.2020.03.062.
  18. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77(6):683–690. DOI: 10.1001/jamaneurol.2020.1127.
  19. Rajkumar RP. COVID-19 and mental health: A review of the existing literature. Asian J Psychiatr 2020;52:102066. DOI: 10.1016/j.ajp.2020.102066.
  20. Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020;87:18–22. DOI: 10.1016/j.bbi.2020.03.031.
  21. Nalleballe K, Reddy Onteddu S, Sharma R, et al. Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav Immun 2020;88:71–74. DOI: 10.1016/j.bbi.2020.06.020.
  22. Zhang Z, Feng Y, Song R, et al. Prevalence of psychiatric diagnosis and related psychopathological symptoms among patients with COVID-19 during the second wave of the pandemic. Global Health 2021;17(1):44. DOI: 10.1186/s12992-021-00694-4.
  23. He X, Zhang D, Zhang L, et al. Neurological and psychiatric presentations associated with COVID-19. Eur Arch Psychiatry Clin Neurosci 2022;272(1):41–52. DOI: 10.1007/s00406-021-01244-0.
  24. Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020;7:611–627. DOI: 10.1016/S2215-0366(20)30203-0.
  25. Varatharaj A, Thomas N, Ellul MA, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study. Lancet Psychiatry 2020;7(10):875–882. DOI: 10.1016/S2215-0366(20)30287-X.
  26. AEFI: Some common ailments that can be expected after vaccination [cited 2022 April 8]. Available from: https://www.mohfw.gov.in/covid_vaccination/vaccination/common-side-effects-aefi.html.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.